Breaking News
Get 45% Off 0
😎 Watchlist Weekend: Copy legendary investors' portfolios to your watchlist in 1 click
Copy for FREE
Close

Sellas Life Sciences Group Inc (SLS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Sellas Life Sciences's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.630 +0.030    +1.88%
- Closed. Currency in USD
After Hours
1.640
+0.010
+0.613%
- Real-time Data
Type:  Equity
Market:  United States
  • Volume: 2,821,515
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.580 - 1.680
Sellas Life Sciences 1.630 +0.030 +1.88%

SLS Recent Sentiments

 
This page contains information on users’ sentiments for the Sellas Life Sciences Group Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
May 06, 2025 Matteo Cascavilla   1.650 +1.21%
May 05, 2025 Peter Bogart   1.715 -4.96%
Apr 28, 2025 EFTYCHIOS PAPATZANAKI   1.397 +16.68%
Apr 23, 2025 kabir Karimi   1.355 May 16, 2025 @ 1.620 +19.56%
Apr 23, 2025 jose Gómez   1.355 May 16, 2025 @ 1.620 +19.56%
Apr 15, 2025 KIKO García   1.160 Apr 21, 2025 @ 1.370 +18.10%
Mar 24, 2025 jose Gómez   1.207 Apr 18, 2025 @ 1.310 +8.53%
Mar 17, 2025 Pete Tuupainen   1.120 Apr 11, 2025 @ 1.120 0.00%
Feb 24, 2025 jose Gómez   1.170 Mar 21, 2025 @ 1.200 +2.56%
Feb 24, 2025 Fares Atta   1.180 Mar 21, 2025 @ 1.200 +1.69%
Feb 10, 2025 Ozan Pehlivan   1.230 Mar 07, 2025 @ 1.190 -3.25%
Feb 07, 2025 Luna ant   1.410 Feb 10, 2025 @ 1.283 -9.01%
Feb 04, 2025 Quim Marti   1.490 Feb 10, 2025 @ 1.283 -13.89%
Feb 04, 2025 בן נוי   1.414 Feb 10, 2025 @ 1.283 -9.26%
Feb 04, 2025 Alberto Tomas   1.520 Feb 10, 2025 @ 1.283 -15.59%
Feb 03, 2025 Ok Ok   1.560 Feb 10, 2025 @ 1.283 -17.76%
Feb 03, 2025 Jose Antonio Santana   1.580 Feb 20, 2025 @ 1.310 -17.09%
Feb 03, 2025 Moshe Saar   1.830 Feb 28, 2025 @ 1.180 -35.52%
Feb 03, 2025 andrea monachesi   1.680 Feb 10, 2025 @ 1.283 -23.63%
Jan 31, 2025 Ok Ok   1.550 Feb 03, 2025 @ 1.480 +4.52%
Jan 31, 2025 Cm Soo   1.379 Feb 03, 2025 @ 1.480 +7.32%
Jan 30, 2025 AWAD ALGHAMDI   1.316 Feb 13, 2025 @ 1.270 -3.50%
Jan 28, 2025 jose Gómez   1.430 Feb 21, 2025 @ 1.270 -11.19%
Jan 28, 2025 Lisbet Sanchez   1.350 Feb 03, 2025 @ 1.480 +9.63%
Jan 27, 2025 عبدالله عبدالله   1.395 Feb 21, 2025 @ 1.270 -8.96%
Jan 27, 2025 Jfjgg Ydjfd   1.349 Feb 21, 2025 @ 1.270 -5.86%
Jan 27, 2025 Alberto Tomas   1.220 Feb 03, 2025 @ 1.480 +21.31%
Jan 27, 2025 KIKO García   1.241 Feb 03, 2025 @ 1.480 +19.26%
Jan 21, 2025 Thatti Kantiya   1.125 Feb 14, 2025 @ 1.320 +17.33%
Jan 21, 2025 Carlos Elcano   1.165 Feb 01, 2025 @ 1.620 +39.06%
Jan 16, 2025 Guillaume Allart   0.969 Feb 07, 2025 @ 1.370 +41.38%
Jan 16, 2025 KIKO García   0.970 Jan 20, 2025 @ 1.060 +9.28%
Jan 14, 2025 Walkiria Vaz   0.960 Jan 20, 2025 @ 1.060 +10.42%
Jan 08, 2025 KIKO García   1.020 Jan 13, 2025 @ 0.900 -11.76%
Jan 07, 2025 Abdullah H   1.035 Jan 13, 2025 @ 0.900 -13.04%
Jan 07, 2025 karim Adel Helmy   1.025 Jan 13, 2025 @ 0.900 -12.20%
Dec 26, 2024 Matteo Cascavilla   1.000 Jan 17, 2025 @ 1.060 -6.00%
Dec 10, 2024 David González   1.004 Dec 16, 2024 @ 0.910 -9.36%
Dec 10, 2024 Quim Marti   0.994 Dec 16, 2024 @ 0.910 +8.45%
Dec 09, 2024 Ni Tefe   1.100 Dec 09, 2024 @ 1.090 +0.91%
Dec 09, 2024 Ni Tefe   1.100 Dec 09, 2024 @ 1.115 -1.36%
Dec 09, 2024 Ni Tefe   1.105 Dec 09, 2024 @ 1.105 0.00%
Dec 09, 2024 Quim Marti   1.190 Dec 09, 2024 @ 1.080 -9.24%
Nov 27, 2024 Ni Tefe   1.185 Dec 04, 2024 @ 1.185 0.00%
Nov 27, 2024 Samet Suna   1.190 Dec 20, 2024 @ 0.901 -24.29%
Nov 27, 2024 Ni Tefe   1.215 Nov 27, 2024 @ 1.225 -0.82%
Nov 27, 2024 Ni Tefe   1.235 Nov 27, 2024 @ 1.230 +0.40%
Nov 27, 2024 Ni Tefe   1.245 Nov 27, 2024 @ 1.240 +0.40%
Nov 27, 2024 Ni Tefe   1.240 Nov 27, 2024 @ 1.240 0.00%
Nov 26, 2024 Ni Tefe   1.180 Nov 26, 2024 @ 1.190 -0.85%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SLS Comments

Write your thoughts about Sellas Life Sciences Group Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Logan Sothirajah
Logan Sothirajah Feb 24, 2025 4:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
fda approval coming
Antoine Neaime
Antoine Neaime Nov 15, 2022 11:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will go up now to 2.4🚀🚀🚀
Mr Worldwide
Mr Worldwide Jul 21, 2021 2:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
gains
May Fong Jennifer Chong
May Fong Jennifer Chong Jul 21, 2021 2:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
cannot see it on its chart
Zoran Labus
Zoran Labus Jun 24, 2021 10:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
To clarify, this is a report for alignant pleural mesothelioma (MPM). which is in the first stageThe report for Acute Myeloid Leukemia (AML) which is in the third phase is coming out by the end of June. you have to wait, for now everything is ok
Zoran Labus
Zoran Labus Jun 24, 2021 9:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Updated Data Show Median Overall Survival of 35.4 Weeks in Patients Treated With Combination Therapy for at Least One Month – Median Overall Survival in Relapse/Refractory Patients with Standard of Care is Approximately 28 weeksNew and Updated Clinical and Translational Data Expected by End of Q4 2021NEW YORK, June 24, 2021 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS" or the “Company”), a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies for a broad range of indications, today announced encouraging updated clinical data from a Phase 1 investigator-sponsored clinical trial of its lead clinical candidate, galinpepimut-S (GPS), combined with the checkpoint inhibitor nivolumab (Opdivo®) in patients with macroscopic (measurable) deposits of malignant pleural mesothelioma (MPM).
Zoran Labus
Zoran Labus Jun 24, 2021 8:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
very good test results
Nonoy Jaca
Nonoy Jaca Jun 23, 2021 11:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
👍👍
Zoran Labus
Zoran Labus Jun 23, 2021 9:23AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
soon going to 30-50
Exar Kun
Exar Kun Jun 22, 2021 9:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Russel microcap index add.... Good...
Tom Pokos
Tom Pokos Jun 14, 2021 5:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Been in this from $2 21000shares I believe life changer
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email